E Chantelau. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Diabetes Mellitus, Type 2/complicationsDiabetes Mellitus, Type 2/drug therapyDiabetic Retinopathy/etiologyHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic useInsulin/adverse effectsInsulin/analogs & derivativesInsulin/therapeutic useInsulin GlargineInsulin, Long-ActingRandomized Controlled Trials as Topic
Substances: See more » Hypoglycemic AgentsInsulinInsulin, Long-ActingInsulin Glargine
Year: 2009 PMID: 19680626 DOI: 10.1007/s00125-009-1488-3
Source DB: PubMed Journal: Diabetologia ISSN: 0012-186X Impact factor: 10.122